Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat in Children With Malignant Soft Tissue Sarcoma Harboring PAX-family Gene Abnormalities
NCT07888114Phase 1Recruiting
- Sponsor
- Beijing Tongren Hospital
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of entinostat in soft tissue sarcoma (STS) (2 cohorts), sponsored by Beijing Tongren Hospital. Primary endpoint: Incidence of adverse events and Grade >=3 AEs. Started Mar 2025; status: recruiting.
02
Drugs
entinostat
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT07888114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07888114.